IL10 and neuroblastoma: This study has also identified that neuroblastoma patients with an age of ≥18 months had higher expression of inflammation-related genes (IL10, IL6R, CD16, CD33, and FCGR3), as compared to patients diagnosed at age ≤ 18 months.